While both B cells and NK cells were implicated in mediating the tumor growth delay observed in Axl KO tumors (Figure 4), prior work from our laboratory has shown that pharmacologic inhibition of Axl increases NK cell activation [21]. The gene discussed is AXL; the disease is neoplasm.